New thiopyrazolo[3,4-d]pyrimidine derivatives as anti-mycobacterial agents

被引：98

作者：

Ballell, Lluis ^{[1
]}

Field, Robert A.

Chung, Gavin A. C.

Young, Robert J.

机构：

[1] Univ E Anglia, Sch Chem Sci & Pharm, Ctr Carbohydrate Chem, Norwich NR4 7TJ, Norfolk, England

[2] GlaxoSmithKline, Med Res Ctr, Stevenage SG1 2NY, Herts, England

[3] GlaxoSmithKline, MMPD CEDD, DDW, Tres Cantos 28760, Spain

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 06期

基金：

英国生物技术与生命科学研究理事会;

关键词：

anti-mycobacterial; anti-tubercular; thiopyrazolopyrimidines; SAR; SULFOTRANSFERASE INHIBITORS; DISCOVERY; TUBERCULOSIS; DESIGN;

D O I：

10.1016/j.bmcl.2006.12.066

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The multiple parallel synthesis of a series of N,S-bis-alkylated thiopyrazolo[3,4-d]pyrimidines, based on sequential S- then N-alkylation, is reported. These compounds showed significant anti-mycobacterial activity (MICs down to < 2 mu/ml) and their potential as significant drug-like leads is substantiated through cytotoxicity evaluation and in silico profiling. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：1736 / 1740

页数：5

共 33 条

[1] A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles
Adamec, J
Waisser, K
Kunes, J
Kaustová, J
[J]. ARCHIV DER PHARMAZIE, 2005, 338 (08) : 385 - 389
[2] Chloropyrimidines as a new class of antimicrobial agents
Agarwal, N
Srivastava, P
Raghuwanshi, SK
Upadhyay, DN
Sinha, S
Shukla, PK
Ram, VJ
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (04) : 869 - 874
[3] Novel pyrazolo[3,4-d]pyrimidine-based inhibitors of Staphlococcus aureus DNA polymerase III:: Design, synthesis, and biological evaluation
Ali, A
Taylor, GE
Ellsworth, K
Harris, G
Painter, R
Silver, LL
Young, K
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (10) : 1824 - 1830
[4] [Anonymous], GLOB TUB CONTR SURV
[5] Armstrong JI, 2000, ANGEW CHEM INT EDIT, V39, P1303, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1303::AID-ANIE1303>3.0.CO
[6] 2-0
[7] New small-molecule synthetic antimycobacterials
Ballell, L
Field, RA
Duncan, K
Young, RJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) : 2153 - 2163
[8] Bergman MR, 1996, J PHARMACOL EXP THER, V279, P247
[9] CLINICAL EVALUATION OF A NEW ANTIMETABOLITE, 6-MERCAPTOPURINE, IN THE TREATMENT OF LEUKEMIA AND ALLIED DISEASES
BURCHENAL, JH
MURPHY, ML
ELLISON, RR
SYKES, MP
TAN, TC
LEONE, LA
KARNOFSKY, DA
CRAVER, LF
DARGEON, HW
RHOADS, CP
[J]. BLOOD, 1953, 8 (11) : 965 - 999
[10] A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells
Chiosis, G
Timaul, MN
Lucas, B
Munster, PN
Zheng, FF
Sepp-Lorenzino, L
Rosen, N
[J]. CHEMISTRY & BIOLOGY, 2001, 8 (03): : 289 - 299

← 1 2 3 4 →